Company intelligence / Profile preview
Nassington
London, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Nassington is a private biotechnology company focused on the discovery and development of novel therapeutic agents for the treatment of oncology and rare diseases. The company leverages its expertise in medicinal chemistry and molecular biology to identify and optimize small molecule candidates that target critical pathways in disease progression. Nassington's research programs are currently in the pre-clinical stage, with a focus on establishing proof-of-concept and safety profiles for its lead assets. The company aims to address significant unmet medical needs by developing innovative therapies that offer improved efficacy and safety over existing standards of care.
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nassington.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nassington.